NCT06840964View on ClinicalTrials.gov

Effect of Omega 3 in Hypertensive Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

June 3, 2024

Study Completion Date

August 30, 2024

Conditions
HypertensionDyslipidemia
Interventions
DIETARY_SUPPLEMENT

omega 3 ethyl esters at 90%

2 grams/day of omega 3 capsules will be administered orally, for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Mygliol 812

Trial Locations (1)

1642

Santa Maria de la Salud, San Isidro

All Listed Sponsors
collaborator

Gador S.A.

INDUSTRY

lead

Santa Maria de la Salud, Argentina

OTHER